Understanding physical activity patterns in patients with pulmonary arterial hypertension.
Official title: Physical Activity in Pulmonary Arterial Hypertension (ACTiPH)
Funded at University of Pennsylvania · NIH-11194972 · Data updated 2026-11-12
This study looks at how staying active impacts people with pulmonary arterial hypertension (PAH) by using special devices to track their daily movements, with the goal of creating personalized exercise plans that can help improve their health and well-being.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Pennsylvania NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | August 20, 2021 |
| Project end | May 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $913,900 |
| NIH project number | 5R01HL159997-05 |
| Project ID | NIH-11194972 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are adults aged 21 and older who have been diagnosed with pulmonary arterial hypertension.
✕Less likely to help
Patients who are not diagnosed with pulmonary arterial hypertension or those who are unable to participate in physical activity may not benefit from this research.
What this research studies
This research investigates how physical activity affects individuals with pulmonary arterial hypertension (PAH) by using advanced monitoring techniques to capture their daily activity patterns. Instead of relying on traditional exercise tests, the study employs accelerometers to gather detailed data on the intensity, frequency, and duration of physical activity in real-life settings. By analyzing these patterns, the research aims to develop personalized physical activity interventions that could enhance patients' quality of life and overall health outcomes.
Why it matters
Potential benefit: If successful, this research could lead to tailored physical activity programs that significantly improve the quality of life and health outcomes for patients with pulmonary arterial hypertension.
How similar studies have gone: While there have been few studies on physical activity in PAH patients, preliminary findings using traditional accelerometry suggest that this approach may yield valuable insights into patient activity patterns.
Where this research is happening
-
University of Pennsylvania
Philadelphia, United States Active
Researchers
- Principal investigator: Kawut, Steven M — University of Pennsylvania
- Study coordinator: Kawut, Steven M
Related research
Other NIH-funded projects on the same topics.
-
Understanding how blood flow and pressure affect lungs in PAH
This grant studies how abnormal blood flow and pressure contribute to pulmonary arterial hypertension and how patient factors shape these effects, with the aim of guiding better therapies.
-
Asporin as a double-targeted therapy and biomarker for a serious artery disease
This project tests a protein called asporin as both a treatment and a biomarker for pulmonary arterial hypertension (PAH) to help people with this life-threatening condition.
-
Platelets and fibroblasts linked to energy use in a hard-to-treat blood vessel disease
A research team at the University of Pittsburgh is studying how platelet energy metabolism and fibroblast glutamine use interact in systemic sclerosis-related pulmonary arterial hypertension to improve diagnosis and treatment.
-
A biatrial dual‑lumen catheter to help the heart and lungs in pulmonary arterial hypertension
A new double‑lumen catheter is being developed to unload the right side of the heart and protect the lungs for people with pulmonary arterial hypertension.
-
Endothelial inflammation and Src kinase in early pulmonary arterial hypertension
Researchers are studying how inflammation in the lining of blood vessels and a protein called Src kinase contribute to early lung artery remodeling in people with mild PAH.
-
Cardiopulmonary chip model to study right heart disease from high blood pressure in the lungs
A tiny heart-lung chip is being developed to understand why the right side of the heart enlarges in people with pulmonary arterial hypertension and to test targeted treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.